ES528628A0 - Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas. - Google Patents

Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.

Info

Publication number: ES528628A0
Authority: ES; Spain
Prior art keywords: piridazo; piridazinas; pirazolinas; diazepinas; pirazolo
Prior art date: 1982-05-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

ES528628A

Other languages

English (en)

Other versions

ES8706672A1 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

F Hoffmann La Roche AG

Original Assignee

F Hoffmann La Roche AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-05-12

Filing date

1984-01-02

Publication date

1987-07-16

1984-01-02 Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG

1987-07-16 Publication of ES8706672A1 publication Critical patent/ES8706672A1/es

1987-07-16 Publication of ES528628A0 publication Critical patent/ES528628A0/es

Status Expired legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/04—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/409—Compounds containing the structure P(=X)-X-acyl, P(=X) -X-heteroatom, P(=X)-X-CN (X = O, S, Se)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650905—Six-membered rings having the nitrogen atoms in the positions 1 and 2
- C07F9/650947—Six-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Health & Medical Sciences (AREA)
Crystallography & Structural Chemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

ES528628A 1982-05-12 1984-01-02 Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas. Expired ES8706672A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8213850		1982-05-12
GB08305505A GB2128984B (en)	1982-05-12	1983-02-28	Diaza-bicyclic compounds

Publications (2)

Publication Number	Publication Date
ES8706672A1 ES8706672A1 (es)	1987-07-16
ES528628A0 true ES528628A0 (es)	1987-07-16

Family

ID=26282820

Family Applications (6)

Application Number	Title	Priority Date	Filing Date
ES522291A Expired ES8407049A1 (es)	1982-05-12	1983-05-11	Un procedimiento para la preparacion de compuestos biciclicos.
ES528625A Expired ES8505173A1 (es)	1982-05-12	1984-01-02	Un procedimiento para la preparacion de compuestos biciclicos
ES528627A Expired ES8601994A1 (es)	1982-05-12	1984-01-02	Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES528628A Expired ES8706672A1 (es)	1982-05-12	1984-01-02	Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.
ES528630A Expired ES8607970A1 (es)	1982-05-12	1984-01-02	Un procedimiento para la obtencion de derivados de hexahidro-3-oxo-piridinas.
ES554935A Expired ES8800170A1 (es)	1982-05-12	1986-05-14	Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
ES522291A Expired ES8407049A1 (es)	1982-05-12	1983-05-11	Un procedimiento para la preparacion de compuestos biciclicos.
ES528625A Expired ES8505173A1 (es)	1982-05-12	1984-01-02	Un procedimiento para la preparacion de compuestos biciclicos
ES528627A Expired ES8601994A1 (es)	1982-05-12	1984-01-02	Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
ES528630A Expired ES8607970A1 (es)	1982-05-12	1984-01-02	Un procedimiento para la obtencion de derivados de hexahidro-3-oxo-piridinas.
ES554935A Expired ES8800170A1 (es)	1982-05-12	1986-05-14	Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas

Country Status (32)

Country	Link
US (3)	US4512924A (es)
EP (1)	EP0094095B1 (es)
KR (1)	KR890002106B1 (es)
AR (1)	AR240940A1 (es)
AU (1)	AU567873B2 (es)
BG (1)	BG61123B2 (es)
CA (1)	CA1234568A (es)
CS (2)	CS249128B2 (es)
CU (1)	CU21532A3 (es)
DE (2)	DE3317290A1 (es)
DK (1)	DK160612C (es)
DO (1)	DOP1983004163A (es)
DZ (1)	DZ540A1 (es)
ES (6)	ES8407049A1 (es)
FI (1)	FI77244C (es)
FR (1)	FR2531956B1 (es)
GB (1)	GB2128984B (es)
GR (1)	GR77462B (es)
HK (1)	HK91692A (es)
HU (3)	HU198935B (es)
IE (1)	IE56480B1 (es)
IL (1)	IL68620A (es)
IT (1)	IT1212738B (es)
LU (2)	LU84803A1 (es)
MC (1)	MC1515A1 (es)
MY (1)	MY102889A (es)
NL (2)	NL8301640A (es)
NO (1)	NO160368C (es)
PT (1)	PT76681B (es)
SE (1)	SE461792B (es)
SG (1)	SG81192G (es)
ZW (1)	ZW9883A1 (es)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2128984B (en) *	1982-05-12	1985-05-22	Hoffmann La Roche	Diaza-bicyclic compounds
NZ204130A (en) *	1982-05-12	1986-03-14	Hoffmann La Roche	Bicyclic heterocyclic compounds and pharmaceutical compositions
DE3315464A1 (de) *	1983-04-28	1984-10-31	Hoechst Ag, 6230 Frankfurt	Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern
US4801721A (en) *	1984-08-16	1989-01-31	Ryan James W	Stereospecific synthesis of carboxyalkyl peptides
US4692438A (en) *	1984-08-24	1987-09-08	Hoffmann-La Roche Inc.	Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US4826992A (en) *	1985-04-30	1989-05-02	Eli Lilly And Company	2,3-(Dihydro) bicyclic pyrazolidinones
ZA863170B (en) *	1985-04-30	1987-12-30	Lilly Co Eli	7-substituted bicyclic pyrazolidinones
US4940718A (en) *	1985-04-30	1990-07-10	Eli Lilly And Company	7-substituted bicyclic pyrazolidinones, pharmaceutical compositions and use
US4902707A (en) *	1985-04-30	1990-02-20	Eli Lilly And Company	Bicyclic pyrazolidinones, compositions and use
ZW11586A1 (en) *	1985-07-01	1987-12-30	Hoffmann La Roche	Bicyclic compounds
US4832763A (en) *	1985-10-15	1989-05-23	Westinghouse Electric Corp.	Method of stress-relief annealing a magnetic core containing amorphous material
DE3542794A1 (de) *	1985-12-04	1987-06-11	Bayer Ag	Antihypertensives kombinationspraeparat
EP0254032A3 (en) *	1986-06-20	1990-09-05	Schering Corporation	Neutral metalloendopeptidase inhibitors in the treatment of hypertension
EP0566157A1 (en)	1986-06-20	1993-10-20	Schering Corporation	Neutral metalloendopeptidase inhibitors in the treatment of hypertension
GB8629875D0 (en) *	1986-12-15	1987-01-28	Hoffmann La Roche	Pyridazodiazepine derivatives
US5262436A (en) *	1987-03-27	1993-11-16	Schering Corporation	Acylamino acid antihypertensives in the treatment of congestive heart failure
US4956490A (en) *	1989-03-09	1990-09-11	Merck & Co., Inc.	Process for preparing benzylpyruvic acids and esters
ZA902661B (en) *	1989-04-10	1991-01-30	Schering Corp	Mercapto-acyl amino acids
DE3917255A1 (de) *	1989-05-26	1990-11-29	Schopf Masch	Verfahren und vorrichtung zum aufnehmen eines flugzeugbugfahrwerks durch einen flugzeugschlepper
US5011938A (en) *	1989-10-02	1991-04-30	Eli Lilly And Company	7-substituted bicyclic pyrazolidinones
WO1991007386A1 (en) *	1989-11-21	1991-05-30	Schering Corporation	Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors
AU7168091A (en) *	1989-12-22	1991-07-24	Schering Corporation	Mercaptocycloacyl aminoacid endopeptidase inhibitors
US5075302A (en) *	1990-03-09	1991-12-24	Schering Corporation	Mercaptoacyl aminolactam endopeptidase inhibitors
US5173506A (en) *	1990-08-16	1992-12-22	Schering Corporation	N-(mercaptoalkyl)ureas and carbamates
DE59107840D1 (de) *	1990-11-21	1996-06-27	Ciba Geigy Ag	Silylierte Acylphosphinoxide
US5208230A (en) *	1990-12-21	1993-05-04	Merrell Dow Pharmaceuticals	Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
ATE139768T1 (de) *	1991-03-19	1996-07-15	Ciba Geigy Ag	Verbindungen mit herbiziden,acarizider und insektizider wirkung
TW216770B (es) *	1991-07-23	1993-12-01	Hoffmann La Roche
CA2078759C (en) *	1991-09-27	2003-09-16	Alan M. Warshawsky	Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
US5455242A (en) *	1991-09-27	1995-10-03	Merrell Dow Pharmaceuticals Inc.	Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
US5457196A (en) *	1991-09-27	1995-10-10	Merrell Dow Pharmaceuticals Inc.	2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
JPH06107661A (ja) *	1991-10-24	1994-04-19	Upjohn Co:The	イミダゾール誘導体およびこれを有効成分とする医薬組成物
US5442062A (en) *	1991-10-24	1995-08-15	The Upjohn Company	Imidazole derivatives and pharmaceutical compositions containing the same
US5972990A (en) *	1992-04-10	1999-10-26	Brigham And Women's Hospital, Inc.	Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
US5977160A (en) *	1992-04-10	1999-11-02	Brigham And Women's Hospital, Inc.	Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
US5552397A (en) *	1992-05-18	1996-09-03	E. R. Squibb & Sons, Inc.	Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
WO1993023403A1 (en) *	1992-05-15	1993-11-25	Merrell Dow Pharmaceuticals Inc.	NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
EP0570764B1 (de) *	1992-05-18	2001-07-18	F.Hoffmann-La Roche & Co. Aktiengesellschaft	Asymmetrische Hydrierung
US5238932A (en) *	1992-05-20	1993-08-24	Merrell Dow Pharmaceuticals Inc.	Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
NZ256589A (en) *	1992-10-30	1996-05-28	Merrell Dow Pharma	Condensed azepine analogues and medicaments (where a is c, o or s and b is o or s)
JPH072859A (ja) *	1993-01-28	1995-01-06	Upjohn Co:The	ピラゾール誘導体およびこれを有効成分とする医薬組成物
US5476395A (en) *	1993-03-01	1995-12-19	Methode Electronics, Inc.	Planar fuse panel
US5654294A (en) *	1993-05-13	1997-08-05	Bristol-Myers Squibb	Spiro lactam dual action inhibitors
DE59409631D1 (de) *	1993-07-15	2001-02-15	Hoffmann La Roche	Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält
PT750631E (pt) *	1994-02-14	2000-07-31	Merrell Pharma Inc	Novos derivados de dissulfureto de mercapto-aacetilamido-1,3,4,5-tetra-hidro-benzo¬c)azepin-3-ona uteis como inibidores de encefalinase e ace
CA2183314C (en) *	1994-02-14	1999-08-31	Gary A. Flynn	Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
DE69416873T2 (de) *	1994-02-14	1999-07-29	Merrell Pharmaceuticals Inc., Cincinnati, Ohio	Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren
US5530013A (en) *	1994-02-14	1996-06-25	American Home Products Corporation	Venlafaxine in the inducement of cognition enhancement
HUT74584A (en) *	1994-02-14	1997-01-28	Merrell Pharma Inc	Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
US5484783A (en) *	1994-03-24	1996-01-16	Merrell Dow Pharmaceuticals Inc.	Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
DE69514912T2 (de) *	1994-03-24	2000-10-05	Merrell Pharmaceuticals Inc., Cincinnati	Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
DK0751774T3 (da) *	1994-03-24	2003-12-08	Merrell Pharma Inc	Hypocholesterolæmiske mercaptoacetylamiddisulfid-derivater
US5756466A (en)	1994-06-17	1998-05-26	Vertex Pharmaceuticals, Inc.	Inhibitors of interleukin-1β converting enzyme
US5587375A (en) *	1995-02-17	1996-12-24	Bristol-Myers Squibb Company	Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) *	1995-05-17	1999-03-02	Bristol-Myers Squibb	Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5650408A (en) *	1995-06-07	1997-07-22	Karanewsky; Donald S.	Thiazolo benzazepine containing dual action inhibitors
US5635504A (en) *	1995-06-07	1997-06-03	Bristol-Myers Squibb Co.	Diazepine containing dual action inhibitors
FR2777889B1 (fr) *	1998-04-27	2004-07-09	Hoechst Marion Roussel Inc	Nouveaux derives de l'acide octahydro-6,10-dioxo-6h- pyridazino[1,2-a][1,2]diazepine-1-carboxylique, leur procede de preparation et leur application a la preparation de composes therapeutiquement actifs
AU2003200034B2 (en) *	1998-04-27	2006-07-20	Aventis Pharma S.A.	New derivatives of octahydro-6, 10-dioxo-6H-pyridazino [1,2-A][1,2]diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds
FR2777888B1 (fr) *	1998-04-27	2004-07-16	Hoechst Marion Roussel Inc	Nouveaux derives de l'acide (3,4,7,8,9,10-hexahydro-6,10- dioxo-6h-pyridazino[1,2-a][1,2]diazepine-1-carboxylique, leur procede de preparation et leur application a la preparation de medicaments
US6703500B2 (en)	1998-08-19	2004-03-09	Vertex Pharmaceuticals, Incorporated	Method of preparing bicyclic intermediates from piperazic acid or an ester thereof useful in the manufacture of caspase inhibitors
US6177565B1 (en) *	1998-08-19	2001-01-23	Vertex Pharmaceuticals Inc.	Process for synthesizing piperazic acid
US6559304B1 (en) *	1998-08-19	2003-05-06	Vertex Pharmaceuticals Incorporated	Method for synthesizing caspase inhibitors
FR2788276B1 (fr) *	1999-01-12	2001-02-16	Hoechst Marion Roussel Inc	NOUVEAU PROCEDE DE PREPARATION DE COMPOSES BICYCLIQUES ET L'APPLICATION DE CE PROCEDE COMME ETAPE INTERMEDIAIRE POUR LA PREPARATION D'UN COMPOSE INHIBITEUR DE L'ENZYME DE CONVERSION DE L'INTERLEUKINE 1-BETA (ice)
EP1216037A2 (en) *	1999-09-21	2002-06-26	Emory University	Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
US20030113330A1 (en) *	1999-11-08	2003-06-19	Uhal Bruce D.	Methods for treating pulmonary fibrosis
US8101363B2 (en)	2000-12-14	2012-01-24	The Brigham And Women's Hospital, Inc.	Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes
GB0119305D0 (en)	2001-04-12	2001-10-03	Aventis Pharma Gmbh	Mercaptoacetylamide derivatives,a process for their preparation and their use
CA2484897C (en)	2002-05-09	2015-10-06	The Brigham And Women's Hospital, Inc.	Soluble st2 as a cardiovascular disease marker and therapeutic target
US20040110241A1 (en) *	2002-12-06	2004-06-10	Segal Mark S.	Materials and methods for monitoring vascular endothelial function
EP1585500B8 (en)	2002-12-20	2017-07-26	Auritec Pharmaceuticals	Coated particles for sustained-release pharmaceutical administration
EP1603916A1 (en) *	2003-03-06	2005-12-14	Ranbaxy Laboratories, Ltd.	Enantiomerically pure cilazapril, process for preparation
WO2005003134A1 (en) *	2003-07-07	2005-01-13	Hetero Drugs Limited	A novel process for the preparation of cilazapril
AU2004315596B2 (en)	2003-08-29	2011-11-24	President And Fellows Of Harvard College	Inhibitors of cellular necrosis
JP4625812B2 (ja)	2003-12-05	2011-02-02	ザクリーブランドクリニックファウンデーション	心臓血管疾患に対するリスクマーカー
US7803838B2 (en) *	2004-06-04	2010-09-28	Forest Laboratories Holdings Limited	Compositions comprising nebivolol
WO2005122682A2 (en)	2004-06-18	2005-12-29	Ranbaxy Laboratories Limited	Process for the preparation of esters of piperazic acid
WO2006042192A2 (en)	2004-10-06	2006-04-20	The Brigham And Womens's Hospital, Inc.	Relevance of achieved levels of markers of systemic inflammation following treatment
AU2006206249A1 (en) *	2005-01-21	2006-07-27	Nicox S.A.	Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use
NZ560386A (en) *	2005-01-31	2009-12-24	Mylan Lab Inc	Pharmaceutical composition comprising hydroxylated nebivolol
EP2174658A1 (en)	2005-05-31	2010-04-14	Mylan Laboratories, Inc	Compositions comprising nebivolol
US8119358B2 (en)	2005-10-11	2012-02-21	Tethys Bioscience, Inc.	Diabetes-related biomarkers and methods of use thereof
DK1864677T3 (da)	2006-06-02	2008-04-28	Teva Pharma	Stabil formulering omfattende et fugtsensitivt lægemiddel og fremstillingsmetoder deraf
US20070281000A1 (en) *	2006-06-02	2007-12-06	Michael Fox	Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
CA2659082A1 (en)	2006-06-07	2007-12-21	Tethys Bioscience, Inc.	Markers associated with arteriovascular events and methods of use thereof
US20080008751A1 (en) *	2006-07-10	2008-01-10	Michael Fox	Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
TW200849035A (en)	2007-04-18	2008-12-16	Tethys Bioscience Inc	Diabetes-related biomarkers and methods of use thereof
US7828840B2 (en) *	2007-11-15	2010-11-09	Med Institute, Inc.	Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
GB2460915B (en)	2008-06-16	2011-05-25	Biovascular Inc	Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
EP2221299A3 (en)	2009-02-11	2010-11-03	Dr. Reddy's Laboratories Ltd.	Preparation of cilazapril intermediates
JP2013518618A (ja)	2010-02-01	2013-05-23	ザ・ホスピタル・フォー・シック・チルドレン	再狭窄を治療および予防するための遠隔虚血コンディショニング
KR20190000368A (ko)	2010-03-31	2019-01-02	더 호스피탈 포 식 칠드런	심근 경색 후 결과를 개선시키기 위한 원격 허혈 처치의 사용
EP2555692A2 (en)	2010-04-08	2013-02-13	The Hospital For Sick Children	Use of remote ischemic conditioning for traumatic injury
WO2012049646A1 (en)	2010-10-12	2012-04-19	Ranbaxy Laboratories Limited	Process for the preparation of an intermediate of cilazapril
EP2537534B1 (en)	2011-06-22	2014-12-17	Hexal AG	Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.
BR112014001283A2 (pt)	2011-07-18	2017-02-21	Critical Care Diagnostics Inc	métodos de tratamento de doenças cardiovasculares e prevenção da eficácia da terapia de exercício
SG11201407402TA (en)	2012-05-11	2014-12-30	Reset Therapeutics Inc	Carbazole-containing sulfonamides as cryptochrome modulators
AU2013296803B2 (en)	2012-08-01	2018-03-08	Eric Ostertag	Free flowing, frozen compositions comprising a therapeutic agent
WO2014145022A1 (en)	2013-03-15	2014-09-18	President And Fellows Of Harvard College	Hybrid necroptosis inhibitors
KR102069473B1 (ko)	2013-03-21	2020-01-22	유프락시아 파마수티컬스 유에스에이 엘엘씨	주입가능한 서방성 방출 조성물 및 관절 내 염증 및 이와 관련된 통증을 치료하기 위해 이를 사용하는 방법
TWI690521B (zh)	2014-04-07	2020-04-11	美商同步製藥公司	作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
TR201808237T4 (tr)	2015-10-27	2018-07-23	Eupraxia Pharmaceuticals Inc	Lokal anestetiklerin sürekli salım formülasyonları.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL58849A (en) *	1978-12-11	1983-03-31	Merck & Co Inc	Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL60617A0 (en) *	1979-07-23	1980-09-16	Sparamedica Ag	Triazolopyridazine derivative,their preparation and pharmaceutical compositions containing them
DE3062972D1 (en) *	1979-09-19	1983-06-09	Hoffmann La Roche	Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives
EP0042100A1 (de) *	1980-06-13	1981-12-23	F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft	Pyrazolopyridazin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung, sowie diese enthaltende Arzneimittel
DE3169261D1 (en) *	1980-09-10	1985-04-18	Beecham Group Plc	Aryl diazabicyclyl amides, a process for their preparation and use
GB2128984B (en) *	1982-05-12	1985-05-22	Hoffmann La Roche	Diaza-bicyclic compounds

1983
- 1983-02-28 GB GB08305505A patent/GB2128984B/en not_active Expired
- 1983-04-29 ZW ZW98/83A patent/ZW9883A1/xx unknown
- 1983-04-29 CA CA000427095A patent/CA1234568A/en not_active Expired
- 1983-05-02 DK DK194783A patent/DK160612C/da not_active IP Right Cessation
- 1983-05-06 IL IL68620A patent/IL68620A/xx not_active IP Right Cessation
- 1983-05-09 HU HU875410A patent/HU198935B/hu unknown
- 1983-05-09 NL NL8301640A patent/NL8301640A/nl not_active Application Discontinuation
- 1983-05-09 HU HU831589A patent/HU195965B/hu unknown
- 1983-05-09 CU CU8335899A patent/CU21532A3/xx unknown
- 1983-05-09 IT IT8321000A patent/IT1212738B/it active
- 1983-05-09 AU AU14364/83A patent/AU567873B2/en not_active Expired
- 1983-05-09 HU HU875409A patent/HU199842B/hu not_active IP Right Cessation
- 1983-05-10 DZ DZ836846A patent/DZ540A1/fr active
- 1983-05-10 MC MC821633A patent/MC1515A1/xx unknown
- 1983-05-10 FR FR8307785A patent/FR2531956B1/fr not_active Expired
- 1983-05-11 NO NO831675A patent/NO160368C/no not_active IP Right Cessation
- 1983-05-11 DE DE19833317290 patent/DE3317290A1/de not_active Ceased
- 1983-05-11 CS CS833303A patent/CS249128B2/cs unknown
- 1983-05-11 ES ES522291A patent/ES8407049A1/es not_active Expired
- 1983-05-11 EP EP83104668A patent/EP0094095B1/de not_active Expired - Lifetime
- 1983-05-11 IE IE1084/83A patent/IE56480B1/en not_active IP Right Cessation
- 1983-05-11 AR AR292991A patent/AR240940A1/es active
- 1983-05-11 LU LU84803A patent/LU84803A1/de unknown
- 1983-05-11 DE DE8383104668T patent/DE3381884D1/de not_active Expired - Lifetime
- 1983-05-11 KR KR1019830002033A patent/KR890002106B1/ko not_active IP Right Cessation
- 1983-05-11 SE SE8302716A patent/SE461792B/sv not_active IP Right Cessation
- 1983-05-12 US US06/493,876 patent/US4512924A/en not_active Expired - Lifetime
- 1983-05-12 DO DO1983004163A patent/DOP1983004163A/es unknown
- 1983-05-12 FI FI831661A patent/FI77244C/fi not_active IP Right Cessation
- 1983-05-12 PT PT76681A patent/PT76681B/pt unknown
- 1983-05-12 GR GR71331A patent/GR77462B/el unknown
1984
- 1984-01-02 ES ES528625A patent/ES8505173A1/es not_active Expired
- 1984-01-02 ES ES528627A patent/ES8601994A1/es not_active Expired
- 1984-01-02 ES ES528628A patent/ES8706672A1/es not_active Expired
- 1984-01-02 ES ES528630A patent/ES8607970A1/es not_active Expired
1985
- 1985-02-01 US US06/697,559 patent/US4658024A/en not_active Expired - Lifetime
1986
- 1986-05-14 ES ES554935A patent/ES8800170A1/es not_active Expired
- 1986-11-28 US US06/936,003 patent/US4772701A/en not_active Expired - Lifetime
1987
- 1987-09-08 MY MYPI87001597A patent/MY102889A/en unknown
1991
- 1991-12-23 CS CS914021A patent/CS402191A3/cs unknown
1992
- 1992-08-12 SG SG811/92A patent/SG81192G/en unknown
- 1992-11-19 HK HK916/92A patent/HK91692A/xx not_active IP Right Cessation
1993
- 1993-06-09 LU LU88299C patent/LU88299I2/fr unknown
- 1993-06-11 NL NL930055C patent/NL930055I2/nl unknown
1994
- 1994-02-21 BG BG098502A patent/BG61123B2/bg unknown

Also Published As

Publication number	Publication date
PT76681B (en)	1986-05-20
NL930055I1 (nl)	1993-09-01
DK160612B (da)	1991-04-02
IL68620A (en)	1987-11-30
ES528630A0 (es)	1986-06-16
ES528627A0 (es)	1985-11-16
SE461792B (sv)	1990-03-26
ES528625A0 (es)	1985-05-16
FI77244B (fi)	1988-10-31
SE8302716L (sv)	1983-11-13
DK194783D0 (da)	1983-05-02
LU84803A1 (fr)	1985-03-21
CS402191A3 (en)	1992-10-14
EP0094095A3 (en)	1984-11-21
DE3381884D1 (de)	1990-10-25
HU195965B (en)	1988-08-29
DOP1983004163A (es)	1988-09-20
AU567873B2 (en)	1987-12-10
IT1212738B (it)	1989-11-30
GB2128984A (en)	1984-05-10
ES8601994A1 (es)	1985-11-16
DE3317290A1 (de)	1983-11-17
IL68620A0 (en)	1983-09-30
CA1234568A (en)	1988-03-29
IT8321000A0 (it)	1983-05-09
US4658024A (en)	1987-04-14
DK160612C (da)	1991-09-23
ES8706672A1 (es)	1987-07-16
ES8800170A1 (es)	1987-11-01
PT76681A (en)	1983-06-01
EP0094095A2 (de)	1983-11-16
HU199842B (en)	1990-03-28
FR2531956A1 (fr)	1984-02-24
FI831661A0 (fi)	1983-05-12
ES522291A0 (es)	1984-08-16
HU198935B (en)	1989-12-28
DK194783A (da)	1983-11-13
GB2128984B (en)	1985-05-22
MY102889A (en)	1993-03-31
GR77462B (es)	1984-09-24
NL930055I2 (nl)	1993-10-01
US4512924A (en)	1985-04-23
IE831084L (en)	1983-11-12
DZ540A1 (fr)	2004-09-13
FI77244C (fi)	1989-02-10
SG81192G (en)	1993-01-29
AR240940A1 (es)	1991-03-27
ES8407049A1 (es)	1984-08-16
US4772701A (en)	1988-09-20
CS249128B2 (en)	1987-03-12
BG61123B2 (bg)	1996-11-29
ZW9883A1 (en)	1984-11-21
AR240940A2 (es)	1991-03-27
KR890002106B1 (ko)	1989-06-19
NO160368C (no)	1989-04-12
HK91692A (en)	1992-11-27
AU1436483A (en)	1983-11-17
CU21532A3 (en)	1987-06-09
FI831661L (fi)	1983-11-13
NO831675L (no)	1983-11-14
NL8301640A (nl)	1983-12-01
SE8302716D0 (sv)	1983-05-11
LU88299I2 (fr)	1994-09-09
FR2531956B1 (fr)	1987-02-20
ES554935A0 (es)	1987-11-01
ES8607970A1 (es)	1986-06-16
NO160368B (no)	1989-01-02
EP0094095B1 (de)	1990-09-19
IE56480B1 (en)	1991-08-14
KR840004754A (ko)	1984-10-24
ES8505173A1 (es)	1985-05-16
MC1515A1 (fr)	1984-02-10
GB8305505D0 (en)	1983-03-30

Publication	Publication Date	Title
ES528628A0 (es)	1987-07-16	Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.
ES523858A0 (es)	1985-04-16	Un procedimiento para la preparacion de benzotienil benzofuranil o naftil-derivados.
ES504291A0 (es)	1983-01-01	Un procedimiento para la preparacion de benzotio-en y benzofuransulfonamidas.
ES519559A0 (es)	1984-02-01	Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.
ES524320A0 (es)	1985-04-16	Un procedimiento para la preparacion de 4-amino-6,7-dimetoxi quinoles.
ES533753A0 (es)	1985-10-01	Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas.
ES501645A0 (es)	1983-02-01	Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES506969A0 (es)	1983-07-01	Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES520730A0 (es)	1984-04-16	Un procedimiento para la prepracion de nuevas benzolactamas.
ES505464A0 (es)	1983-01-01	Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
ES524271A0 (es)	1984-11-16	Un procedimiento para la preparacion de nuevos derivados de daunorrubicina y doxorrubicina.
ES530418A0 (es)	1985-12-01	Un procedimiento para la preparacion de pirazolopiridinas.
ES507507A0 (es)	1982-09-01	Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
ES503307A0 (es)	1983-02-01	Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES515158A0 (es)	1983-06-01	Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES522120A0 (es)	1984-12-01	Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES520812A0 (es)	1983-12-16	Procedimiento para la preparacion de 3-azolil-1,2-diaril-1-halogeno-1-propenos.
ES509312A0 (es)	1983-03-16	Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona.
ES501077A0 (es)	1982-06-01	Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas.
ES509432A0 (es)	1983-03-16	Un procedimiento para la preparacion de arilaminas.
ES535551A0 (es)	1986-05-16	Un procedimiento para la preparacion de nuevos 16-fluor-16,17-dideshidro prostanoides.
ES527780A0 (es)	1985-11-16	Un procedimiento para la preparacion de nuevas espiro-3-azolindionas.
ES507919A0 (es)	1983-01-16	Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.
ES514336A0 (es)	1983-04-16	Un procedimiento para la preparacion de guanidinas.
ES514892A0 (es)	1983-10-16	Un metodo para la preparacion de 2-hidroxi-aclacinomicinas a, b y n.

Legal Events

Date	Code	Title	Description
2007-12-16	FD1A	Patent lapsed	Effective date: 20070411